Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide
- 1 January 2007
- journal article
- research article
- Published by Informa UK Limited in Autoimmunity
- Vol. 40 (1), 23-30
- https://doi.org/10.1080/08916930601168093
Abstract
The objective of this study was to determine the expression of transforming growth factor-beta1 messenger RNA (TGF-β1 mRNA) and the expression of mRNA for TGF-β receptors (TGF-β Rs mRNA) in whole peripheral blood of consecutive (treated from several months to several years) systemic lupus erythematosus (SLE) patients (21 women). A further aim of this study was to evaluate the association between expression of the above mentioned parameters in relation to the form of applied therapy (9 patients treated with quinagolide and 12 with quinagolide plus prednisone, azathioprine or cyclosporine A). The control group consisted of 15 healthy women. Most of the patients had mild SLE with SLE disease activity index (SLEDAI) score < 10 at time when blood samples were collected. Laboratory measurements included real-time polymerase chain reaction (RT-QPCR). The expression levels of TGF-β1 mRNA and mRNA for TGF-β RII and RIII were significantly lower in patients whereas the expression level of TGF-β RI was statistically significantly higher in SLE patients than in the controls. A very high positive correlation between TGF-β1 mRNA expression and expression levels of TGF-β Rs mRNA was found. In compared subgroups selected according to the form of the applied therapy no statistically significant differences were observed. We conclude that the TGF-β signaling pathway can be altered in circulating leukocytes derived from treated patients with SLE and that the assumed forms of the applied therapy in the group of patients under consideration are accompanied by similarity in the expression level of transcripts for TGF-β1 and TGF-β Rs determined in whole blood. In our investigations, we cannot exclude the influence of the disease itself on the obtained results.Keywords
This publication has 27 references indexed in Scilit:
- Human cytomegalovirus in patients with systemic lupus erythematosusAutoimmunity, 2005
- Analyses of serum levels of type 1, type 2 and type 3 cytokines reveal multiple abnormalities in lupus-prone (NZB x NZW) F1 miceInternational Journal of Rheumatic Diseases, 2004
- Corticosteroids stimulate selectively transforming growth factor (TGF)-β receptor type III expression in transdifferentiating hepatic stellate cellsJournal of Hepatology, 2004
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced ResponsesPublished by Elsevier BV ,2003
- The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosusLupus, 2003
- The Increased Interleukin-13 in Patients with Systemic Lupus Erythematosus: Relations to Other Thl-, Th2-Related Cytokines and Clinical FindingsAutoimmunity, 2001
- Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 1992
- Polyclonal B Cell Activation and Antigen-Driven Antibody Response as Mechanisms of Autoantibody Production InsleAutoimmunity, 1990
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985